WATSON 460 (Glipizide 5 mg)
Pill imprint WATSON 460 has been identified as Glipizide 5 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Glipizide
- Imprint:
- WATSON 460
- Strength:
- 5 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-0460
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
lactose anhydrous
microcrystalline cellulose
corn starch
stearic acid
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-3841 | A-S Medication Solutions, LLC (repackager) |
| 63874-0316 | Altura Pharmaceuticals Inc (repackager) |
| 55289-0806 | PDRX Pharmaceuticals Inc (repackager) |
| 53002-0446 | Pharmedix (repackager) |
Note: Inactive ingredients may vary.
More about glipizide
Consumer resources
- Other brands: Glucotrol, Glucotrol XL, GlipiZIDE XL
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
